Kim J M van der Velden - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Learning Health Systems|July 18, 2025

Moving from a registry to a learning health system: A case study of a Dutch prostate cancer registryTom Belleman, Jeroen D H van Wijngaarden, Malou C P Kuppen, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024

The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer PatientsDianne Bosch, Kim J M van der Velden, Irma M Oving, et al.

Clinical Genitourinary Cancer|March 13, 2025

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Dianne Bosch, Kim J M van der Velden, Tom Belleman, et al.

Drugs - Real World Outcomes|May 9, 2026

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate CancerDianne Bosch, Kim J M van der Velden, Aart Beeker, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Learning Health Systems|July 18, 2025

Moving from a registry to a learning health system: A case study of a Dutch prostate cancer registryTom Belleman, Jeroen D H van Wijngaarden, Malou C P Kuppen, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024

The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer PatientsDianne Bosch, Kim J M van der Velden, Irma M Oving, et al.

Clinical Genitourinary Cancer|March 13, 2025

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Dianne Bosch, Kim J M van der Velden, Tom Belleman, et al.

Drugs - Real World Outcomes|May 9, 2026

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate CancerDianne Bosch, Kim J M van der Velden, Aart Beeker, et al.

Pageof 1